MOTS-c and SS-31 are both mitochondria-targeting research peptides with fundamentally different mechanisms. This comparison covers cardiolipin protection vs AMPK signalling, clinical trial status, and research applications.
NAD+ and MOTS-c both target mitochondrial function but through fundamentally different mechanisms. This comparison covers electron transport, sirtuin activation, AMPK signalling, age-related decline, and research applications.
Complete MOTS-c research guide covering molecular profile, AMPK mechanism, mitochondrial retrograde signalling, insulin sensitivity, exercise biology, longevity data, and storage specifications.
Complete SS-31 (elamipretide) research guide covering cardiolipin biology, inner mitochondrial membrane targeting, cardiac protection, Barth syndrome, AKI, clinical trial summary, and storage specifications.
